News & Perspective

Oct 27, 2014

Oct 27, 2014

CSL-Novartis deal includes US cell-based flu vaccine plant

The $275 million deal will make the company the second leading player in the $4 billion global flu vaccine market.

Aug 12, 2014

Aug 12, 2014

Flu Scan for Aug 12, 2014

H7N9 in macaques
Flu spike in Australia
Canadian flu vaccine plant

Jun 11, 2014

Jun 11, 2014
Syringe and vials

CSL studies shed light on 2010 flu vaccine seizures

Vaccine strains overstimulated some kids' immune systems, and CSL said it has taken steps to reduce the risk.